Live Quote · NASDAQRLMDHealthcare· Biotechnology

Relmada Therapeutics, Inc.

$2.62▼ 15.76%($-0.49)
MKT CAP $279.54MNEXT EARNINGS Mar 18, 2027
50%
Bullish
TickerSpark Score
52/100
▌ Mixed
70
Valuation
20
Profitability
60
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RLMD research report →

Analyst Price Target
$12.00+358.0% vs. today

Range $12 – $12

Analyst RatingBuy
5 Buy2 Hold1 Sell

Price Chart

-39.35% · this period
$7.86$5.24$2.62Nov 20May 26Nov 20
52-Week Range0% of range
Low
$2.60
Current
$2.62
High
$8.00